Optical coherence tomography: 15 years in cardiology

Circulation Journal

Volumn 77, Issue 8, 2013, Pages 1933-1940

  Yonetsu, Taishi ^a   Bouma, Brett E ^a   Kato, Koji ^a   Fujimoto, James G ^b   Jang, Ik Kyung ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

Author keywords

Coronary artery disease; Optical coherence tomography; Percutaneous coronary intervention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; BARE METAL STENT; CARDIAC ALLOGRAFT VASCULOPATHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; HYPERPLASIA; INTRAVASCULAR ULTRASOUND; MACROPHAGE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; VALIDATION STUDY;

ANIMALS; CORONARY ARTERY DISEASE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PLAQUE, ATHEROSCLEROTIC; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84880839463     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0643.1     Document Type: Review

References (82)

1. Potkin BN, Bartorelli AL, Gessert JM, Neville RF, Almagor Y, Roberts WC, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 1990; 81: 1575-1585.
2. Tobis JM, Mallery J, Mahon D, Lehmann K, Zalesky P, Griffth J, et al. Intravascular ultrasound imaging of human coronary arteries in vivo: Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation 1991; 83: 913-926.
3. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science 1991; 254: 1178-1181.
4. Tanno N, Tsutomu I, Saeki A. Device for measuring light wave of a refected image. Japanese Patent JP04174345. 1992.
5. Puliafto CA, Hee MR, Lin CP, Reichel E, Schuman JS, Duker JS, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995; 102: 217-229.
6. Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, et al. Optical coherence tomography for optical biopsy: Properties and demonstration of vascular pathology. Circulation 1996; 93: 1206-1213.
7. Tearney GJ, Brezinski ME, Boppart SA, Bouma BE, Weissman N, Southern JF, et al. Catheter-based optical imaging of a human coronary artery. Circulation 1996; 94: 3013.
8. Tearney GJ, Brezinski ME, Bouma BE, Boppart SA, Pitvis C, Southern JF, et al. In vivo endoscopic optical biopsy with optical coherence tomography. Science 1997; 276: 2037-2039.
9. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002; 106: 1640-1645.
10. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006; 97: 1713-1717.
11. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Quantifcation of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003; 107: 113-119.
12. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological clas-sifcation scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: 1262-1275.
13. Kume T, Akasaka T, Kawamoto T, Okura H, Watanabe N, Toyota E, et al. Measurement of the thickness of the fbrous cap by optical coherence tomography. Am Heart J 2006; 152: 755.e1-e4.
14. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: Comparison with intravascular ultrasound. J Am Coll Cardiol 2002; 39: 604-609.
15. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005; 111: 1551-1555.
16. Golubovic B, Bouma BE, Tearney GJ, Fujimoto JG. Optical frequency-domain refectometry using rapid wavelength tuning of a Cr4+: Forsterite laser. Optics Lett 1997; 22: 1704-1706.
17. Chinn SR, Swanson EA, Fujimoto JG. Optical coherence tomography using a frequency-tunable optical source. Optics Lett 1997; 22: 340-342.
18. Choma MA, Sarunic MV, Yang CH, Izatt JA. Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Optics Express 2003; 11: 2183-2189.
19. de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE. Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Optics Lett 2003; 28: 2067-2069.
20. Leitgeb R, Hitzenberger CK, Fercher AF. Performance of Fourier domain vs. time domain optical coherence tomography. Optics Express 2003; 11: 889-894.
21. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004; 44: 972-979.
22. Tanaka A, Imanishi T, Kitabata H, Kubo T, Takarada S, Tanimoto T, et al. Morphology of exertion-triggered plaque rupture in patients with acute coronary syndrome: An optical coherence tomography study. Circulation 2008; 118: 2368-2373.
23. Tanimoto T, Imanishi T, Tanaka A, Yamano T, Kitabata H, Takarada S, et al. Various types of plaque disruption in culprit coronary artery visualized by optical coherence tomography in a patient with unstable angina. Circ J 2009; 73: 187-189.
24. Kashiwagi M, Tanaka A, Kitabata H, Tsujioka H, Matsumoto H, Arita Y, et al. Relationship between coronary arterial remodeling, fbrous cap thickness and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome. Circ J 2009; 73: 1291-1295.
25. Ino Y, Kubo T, Tanaka A, Kuroi A, Tsujioka H, Ikejima H, et al. Difference of culprit lesion morphologies between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome: An optical coherence tomography study. JACC Cardio-vasc Interv 2011; 4: 76-82.
26. Fuster V. Lewis A. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology [Conner Memorial Lecture]. Circulation 1994; 90: 2126-2146.
27. Lendon CL, Davies MJ, Born GV, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991; 87: 87-90.
28. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation 2000; 101: 598-603.
29. Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: An intravascular ultrasound study. J Am Coll Cardiol 2001; 37: 63-69.
30. Raffel OC, Merchant FM, Tearney GJ, Chia S, Gauthier DD, Pomerantsev E, et al. In vivo association between positive coronary artery remodelling and coronary plaque characteristics assessed by intravascular optical coherence tomography. Eur Heart J 2008; 29: 1721-1728.
31. Tian J, Hou J, Xing L, Kim SJ, Yonetsu T, Kato K, et al. Signifcance of intraplaque neovascularisation for vulnerability: Optical coherence tomography study. Heart 2012; 98: 1504-1509.
32. Tian J, Hou J, Xing L, Kim SJ, Yonetsu T, Kato K, et al. Does neo-vascularization predict response to statin therapy? Optical coherence tomography study. Int J Cardiol 2012; 158: 469-470.
33. Uemura S, Ishigami K, Soeda T, Okayama S, Sung JH, Nakagawa H, et al. Thin-cap fbroatheroma and microchannel fndings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J; 33: 78-85.
34. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336: 1276-1282.
35. Yonetsu T, Kakuta T, Lee T, Takahashi K, Kawaguchi N, Yamamoto G, et al. In vivo critical fbrous cap thickness for rupture-prone coronary plaques assessed by optical coherence tomography. Eur Heart J 2011; 32: 1251-1259.
36. Lee RM. A critical appraisal of the effects of fxation, dehydration and embedding of cell volume. In: Revel JP, Barnard T, Haggis GH, editors. Scanning electron microscopy. Chicago: AMF O'Hare, 1984; 61-70.
37. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, et al. Non-culprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: A 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012; 5: 433-440.
38. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, et al. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: A 3-vessel optical coherence tomography study. JACC Cardiovasc Interv 2012; 5: 1150-1158.
39. Kato K, Yonetsu T, Jia H, Abtahian F, Vergallo R, Hu S, et al. Non-culprit coronary plaque characteristics of chronic kidney disease. Circ Cardiovasc Imaging 2013; 6: 448-456.
40. Maurovich-Horvat P, Schlett CL, Alkadhi H, Nakano M, Stolzmann P, Vorpahl M, et al. Differentiation of early from advanced coronary atherosclerotic lesions: Systematic comparison of CT, intravascular US, and optical frequency domain imaging with histopathologic examination in ex vivo human hearts. Radiology 2012; 265: 393-401.
41. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, et al. Coronary plaque erosion without rupture into a lipid core: A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996; 93: 1354-1363.
42. Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82: 269-272.
43. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction: Ability of optical coherence tomography compared with intra-vascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007; 50: 933-939.
44. Vergallo R, Yonetsu T, Kato K, Jia H, Abtahian F, Tian J, et al. Evaluation of culprit lesions by optical coherence tomography in patients with ST-elevation myocardial infarction. Int J Cardiol 2013 February 13, doi:10.1016/j.ijcard.2013.01.041 [Epub ahead of print].
45. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, et al. In vivo diagnosis of plaque erosion and calcifed nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol 2013 June 27, doi:10.1016/j.jacc.2013.05.071 [Epub ahead of print].
46. Bouma BE, Tearney GJ, Yabushita H, Shishkov M, Kauffman CR, DeJoseph Gauthier D, et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 2003; 89: 317-320.
47. Kume T, Okura H, Miyamoto Y, Yamada R, Saito K, Tamada T, et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation: Preliminary observation. Circ J 2012; 76: 698-703.
48. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Garcia-Garcia HM, Onuma Y, et al. Relation between plaque type and dissections at the edges after stent implantation: An optical coherence tomography study. Int J Cardiol 2011; 150: 151-155.
49. Gonzalo N, Serruys PW, Okamura T, Shen ZJ, Onuma Y, Garcia-Garcia HM, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: A systematic quantitative approach. Heart 2009; 95: 1913-1919.
50. Kubo T, Imanishi T, Kitabata H, Kuroi A, Ueno S, Yamano T, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: A serial optical coherence tomography study. JACC Cardiovasc Imaging 2008; 1: 475-484.
51. Zeglin-Sawczuk M, Jang IK, Kato K, Yonetsu T, Kim S, Choi SY, et al. Lipid rich plaque, female gender and proximal coronary stent edge dissections. J Thromb Thrombolysis 2013 February 2, doi:10.1007/ s11239-013-0882-3 [Epub ahead of print].
52. Imola F, Occhipinti M, Biondi-Zoccai G, Di Vito L, Ramazzotti V, Manzoli A, et al. Association between proximal stent edge positioning on atherosclerotic plaques containing lipid pools and postproce-dural myocardial infarction (from the CLI-POOL Study). Am J Car-diol 2013; 111: 526-531.
53. Tanigawa J, Barlis P, Di Mario C. Intravascular optical coherence tomography: Optimisation of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 2007; 3: 128-136.
54. Kawamori H, Shite J, Shinke T, Otake H, Matsumoto D, Nakagawa M, et al. Natural consequence of post-intervention stent malapposi-tion, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up. Eur Heart J Cardio-vasc Imaging 2013 January 4, doi:10.1093/ehjci/jes299 [Epub ahead of print].
55. Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: Findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv 2012; 5: 12-20.
56. Kim JS, Fan C, Choi D, Jang IK, Lee JM, Kim TH, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol 2011; 146: 341-346.
57. Kim JS, Jang IK, Fan C, Kim TH, Park SM, Choi EY, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: The ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009; 2: 1240-1247.
58. Kim JS, Kim BK, Jang IK, Shin DH, Ko YG, Choi D, et al. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT). Am Heart J 2012; 163: 601-607.
59. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158: 284-293.
60. Hou J, Jia H, Liu H, Han Z, Yang S, Xu C, et al. Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis. Int J Cardiovasc Imaging 2012; 28: 1879-1886.
61. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Sukmawan R, et al. Visualization of neointima formation by optical coherence tomography. Int Heart J 2005; 46: 1133-1136.
62. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010; 75: 961-963.
63. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, et al. Appearance of lipid-laden intima and neovascularization after implantation of bare-metal stents extended late-phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol 2009; 55: 26-32.
64. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011; 57: 1314-1322.
65. Hou J, Qi H, Zhang M, Ma L, Liu H, Han Z, et al. Development of lipid-rich plaque inside bare metal stent: Possible mechanism of late stent thrombosis? An optical coherence tomography study. Heart 2010; 96: 1187-1190.
66. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, et al. Optical coherence tomographic analysis of in-stent neoatherosclero-sis after drug-eluting stent implantation. Circulation 2011; 123: 2954-2963.
67. Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, et al. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol 2012; 110: 933-939.
68. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Predictors for neoatherosclerosis: A retrospective observational study from the optical coherence tomography registry. Circ Cardiovasc Imaging 2012; 5: 660-666.
69. Alfonso F, Paulo M, Gonzalo N, Dutary J, Jimenez-Quevedo P, Lennie V, et al. Diagnosis of spontaneous coronary artery dissection by optical coherence tomography. J Am Coll Cardiol 2012; 59: 1073-1079.
70. Alfonso F, Hernandez R, Goicolea J, Segovia J, Perez-Vizcayno MJ, Banuelos C, et al. Coronary stenting for acute coronary dissection after coronary angioplasty: Implications of residual dissection. J Am Coll Cardiol 1994; 24: 989-995.
71. Hou J, Lv H, Jia H, Zhang S, Xing L, Liu H, et al. OCT assessment of allograft vasculopathy in heart transplant recipients. JACC Car-diovasc Imaging 2012; 5: 662-663.
72. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, et al. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102: 399-404.
73. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet 2008; 371: 899-907.
74. Yoshimura S, Kawasaki M, Yamada K, Enomoto Y, Egashira Y, Hattori A, et al. Visualization of internal carotid artery atherosclerotic plaques in symptomatic and asymptomatic patients: A comparison of optical coherence tomography and intravascular ultrasound. Am J Neuroradiol 2012; 33: 308-313.
75. Yonetsu T, Kakuta T, Lee T, Takayama K, Kakita K, Iwamoto T, et al. Assessment of acute injuries and chronic intimal thickening of the radial artery after transradial coronary intervention by optical coherence tomography. Eur Heart J 2010; 31: 1608-1615.
76. Karnabatidis D, Katsanos K, Paraskevopoulos I, Diamantopoulos A, Spiliopoulos S, Siablis D. Frequency-domain intravascular optical coherence tomography of the femoropopliteal artery. Cardiovasc Intervent Radiol 2011; 34: 1172-1181.
77. Fukumoto Y, Shimokawa H. Recent progress in the management of pulmonary hypertension. Circ J 2011; 75: 1801-1810.
78. Hou J, Qi H, Zhang M, Meng L, Han Z, Yu B, et al. Pulmonary vascular changes in pulmonary hypertension: Optical coherence tomography fndings. Circ Cardiovasc Imaging 2010; 3: 344-345.
79. Li N, Zhang S, Hou J, Jang IK, Yu B. Assessment of pulmonary artery morphology by optical coherence tomography. Heart Lung Circ 2012; 21: 778-781.
80. Lee T, Yonetsu T, Koura K, Hishikari K, Murai T, Iwai T, et al. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ Cardiovasc Intervent 2011; 4: 378-386.
81. Yonetsu T, Kakuta T, Lee T, Takahashi K, Yamamoto G, Iesaka Y, et al. Impact of plaque morphology on creatine kinase-MB elevation in patients with elective stent implantation. Int J Cardiol 2011; 146: 80-85.
82. Porto I, Di Vito L, Burzotta F, Niccoli G, Trani C, Leone AM, et al. Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography. Circ Cardiovasc Intervent 2012; 5: 89-96, S1-S6.